COMPARISON OF IBI AND PBI CALCULATED FOR 68GA-PSMA AND 18F-FDG IN MULTIPLE MYELOMA PATIENTS
Introduction/Justification: The benefits of using 18F-FDG PET/CT for staging and managing treatment in patients with multiple myeloma (MM) are extensively documented. Recent studies indicate that 68Ga-PSMA PET/CT is also an excellent marker for MM lesions and may complement 18F-FDG due to the signif...
Tallennettuna:
| Päätekijät: | , , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier
2024-04-01
|
| Sarja: | Hematology, Transfusion and Cell Therapy |
| Aiheet: | |
| Linkit: | http://www.sciencedirect.com/science/article/pii/S253113792400169X |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|